Zimbabwe has rejected a major US health deal worth $367m (£272m) spanning five years over the United States' insistence on confidential biological samples.
The decision became public after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesman has since stated that the United States was requesting genetic material for scientific study and commercial purposes but was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to find a agreement agreeable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Implications
Zimbabwe's decision follows a comparable situation in Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.
Based on reports, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Put simply, our country would provide the raw materials for scientific discovery with no certainty that the final treatments would be available to our population if a future health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future co-operation could be structured in a manner that respects the independence and interests of both nations."
Medical Community Response
Medical experts said it acknowledged the government's concerns, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes were funded by international support.
"Where technical issues arise, such as those involving information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it added.
The situation highlights the ongoing tensions between accepting vital international aid and protecting local interests in an ever more interconnected world.